BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31495760)

  • 1. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
    Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading.
    Li WX; Miao F; Xu XQ; Zhang J; Wu ZY; Chen KM; Yan FH; Lin XZ
    Acad Radiol; 2021 Feb; 28(2):208-216. PubMed ID: 32111466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas.
    Hu X; Shi S; Wang Y; Yuan J; Chen M; Wei L; Deng W; Feng ST; Peng Z; Luo Y
    Radiol Med; 2024 Jan; 129(1):1-13. PubMed ID: 37861978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional Texture Analysis Based on CT Images to Differentiate Pancreatic Lymphoma and Pancreatic Adenocarcinoma: A Preliminary Study.
    Huang Z; Li M; He D; Wei Y; Yu H; Wang Y; Yuan F; Song B
    Acad Radiol; 2019 Aug; 26(8):e189-e195. PubMed ID: 30193819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram array and convolutional neural network of DWI for differentiating pancreatic ductal adenocarcinomas from solid pseudopapillary neoplasms and neuroendocrine neoplasms.
    Shi YJ; Zhu HT; Li XT; Zhang XY; Liu YL; Wei YY; Sun YS
    Clin Imaging; 2023 Apr; 96():15-22. PubMed ID: 36736182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5.
    Yu H; Li M; Cao D; Wang Y; Zeng N; Cheng Y; Huang Z; Song B
    Eur J Radiol; 2022 Feb; 147():110100. PubMed ID: 34972060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.
    Ren S; Tang HJ; Zhao R; Duan SF; Chen R; Wang ZQ
    Curr Med Sci; 2022 Feb; 42(1):217-225. PubMed ID: 35089491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resectable pancreatic ductal adenocarcinoma: association between preoperative CT texture features and metastatic nodal involvement.
    Fang WH; Li XD; Zhu H; Miao F; Qian XH; Pan ZL; Lin XZ
    Cancer Imaging; 2020 Feb; 20(1):17. PubMed ID: 32041672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 18. A Novel Multiresolution-Statistical Texture Analysis Architecture: Radiomics-Aided Diagnosis of PDAC Based on Plain CT Images.
    Qiu JJ; Yin J; Qian W; Liu JH; Huang ZX; Yu HP; Ji L; Zeng XX
    IEEE Trans Med Imaging; 2021 Jan; 40(1):12-25. PubMed ID: 32877335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification.
    Takahashi D; Kojima M; Suzuki T; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Nakatsura T; Ochiai A; Nagino M
    Sci Rep; 2018 Sep; 8(1):13166. PubMed ID: 30177687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.